Viewing nowCombinationTwin Cara Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Jeongwoo Pharmaceutical Co., Ltd.

MFDS item code 201902891 · Approved 2019.05.07 · Insurance code 694205600
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or telmisartan. It effectively lowers blood pressure, reducing the burden on the heart and blood vessels and helping to decrease the risk of complications.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine); however, direct switching to this medicine may be considered when blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this medicine 40/10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams and 80/10 milligrams). ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, the administration of this medication should be discontinued as soon as possible. This medication should not be administered to individuals allergic to the active ingredients or similar substances, pregnant or potentially pregnant women, breastfeeding women, patients with severe liver disease, and patients with certain cardiac conditions. Particular caution is needed for patients with liver or gastrointestinal issues, impaired kidney function, and elderly patients when using this medication. Side effects such as dizziness, edema, and blood pressure reduction may occur while taking this medication, so if any abnormal symptoms arise, it is essential to consult healthcare professionals. There may be interactions if taken with other antihypertensive drugs, so it is crucial to inform your doctor or pharmacist if you are taking other medications. This medication is not recommended for breastfeeding women and should be avoided during pregnancy or breastfeeding. Its safety and efficacy have not been sufficiently established for children, so it is advisable not to use it in this population. Elderly patients may be more sensitive to this medication, so dosage adjustment and caution are necessary. In case of overdose, symptoms such as blood pressure reduction, dizziness, and cardiac issues may occur, so immediate contact with healthcare professionals and appropriate treatment are required. This medication should be kept out of reach of children and should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that shields it from light. Additionally, it is essential to store the medication safely at room temperature, between 1 to 30 degrees Celsius.
White or off-white rectangular tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Jeongwoo Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.